ArticleFrontiers in oncology2021

Safety and Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.